ADB announces $9bn COVID-19 vaccine facility

The Asian Development Bank has unveiled a $9 billion vaccine initiative, the Asia Pacific Vaccine Access Facility. APVAX will provide funding for vaccine procurement and logistics costs, as well as for successful distribution, delivery, and administration of vaccines in developing Asia. It will also support important investments to build capacity in vaccine delivery, community outreach, and surveillance.